MedPath
NMPA Approval

Teicoplanin for Injection

国药准字H20249206

October 29, 2024

Drug Information

注射用替考拉宁

注射剂

0.4g(40万单位)

化学药品

October 29, 2024

Company Information

Applicant Company

四川省内江市市中区汉阳路333号3幢

Manufacturing Company

四川省内江市市中区汉阳路333号3幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用替考拉宁 - NMPA 批准文号 | MedPath